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Abstract
Background: Guidelines continue to be underutilized, and a variety of strategies to improve their use have been
suboptimal. Modifying guideline features represents an alternative, but untested way to promote their use. The
purpose of this study was to identify and define features that facilitate guideline use, and examine whether and
how they are included in current guidelines.
Methods: A guideline implementability framework was developed by reviewing the implementation science
literature. We then examined whether guidelines included these, or additional implementability elements. Data
were extracted from publicly available high quality guidelines reflecting primary and institutional care, reviewed
independently by two individuals, who through discussion resolved conflicts, then by the research team.
Results: The final implementability framework included 22 elements organized in the domains of adaptability,
usability, validity, applicability, communicability, accommodation, implementation, and evaluation. Data were
extracted from 20 guidelines on the management of diabetes, hypertension, leg ulcer, and heart failure. Most
contained a large volume of graded, narrative evidence, and tables featuring complementary clinical information.
Few contained additional features that could improve guideline use. These included alternate versions for different
users and purposes, summaries of evidence and recommendations, information to facilitate interaction with and
involvement of patients, details of resource implications, and instructions on how to locally promote and monitor
guideline use. There were no consistent trends by guideline topic.
Conclusions: Numerous opportunities were identified by which guidelines could be modified to support various
types of decision making by different users. New governance structures may be required to accommodate
development of guidelines with these features. Further research is needed to validate the proposed framework of
guideline implementability, develop methods for preparing this information, and evaluate how inclusion of this
information influences guideline use.
Background
Guidelines are syntheses of best available evidence that
support decision making by clinicians, managers, and
policy makers about the organization and delivery of
healthcare, but continue to be underused. Numerous
population-based studies demonstrate low compliance
with guidelines produced by prominent government and
professional agencies for chronic and acute conditions
[1-7]. It has been proposed that for a condition such as
cancer, a third of cases could be prevented, another
third cured, and the remainder effectively treated if
management consistently complied with existing guide-
lines [8]. Thus, it is imperative that we better implement
guidelines.
Many existing implementation strategies have limited
effectiveness and are not routinely applied outside of
experimental research due to their cost and complexity
[9-18]. As a result many guidelines are passively distrib-
uted [19-21]. Surveys of international guideline develo-
pers found that few developers implemented their own
guidelines, had dedicated implementation staff, or evalu-
ated use of their guidelines, and many believed that tar-
get users should be responsible for implementation
[22-25]. Accountability for guideline implementation
may differ by jurisdiction and organization depending
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grams are funded. Hence, there is a need to develop
broadly applicable strategies for implementing
guidelines.
Observational studies have shown that use of guide-
lines is associated with the complexity of the recom-
mended clinical action so a promising, but untested
option is to alter guideline recommendations to make
them more easily implementable by target users [26,27].
Implementability has been referred to as the characteris-
tics of guideline recommendations that may enhance
their implementation, and instruments have been devel-
oped to guide the formulation of implementable recom-
mendations [28,29]. However, research suggests that
including information within guidelines to assist users
with implementation of the recommendations may pro-
mote greater understanding of how users are to accom-
modate the recommendations, which may stimulate
confidence in capacity to practice the recommended
behaviour, leading to greater intent to use guidelines
and possibly actual use [30].
For example, in a systematic review of 256 studies, 41
of them found that lack of comprehensible structure and
local applicability were barriers of guideline use [30].
Two randomized controlled trials (RCTs) examined the
influence of guideline attributes on use. In one RCT, phy-
sicians of various specialties who received a guideline on
electrodiagnostic tests (EDT) for patients with low back
pain that was modified to include vignettes to illustrate
use in patients with differing indications were more likely
to use EDT appropriately compared with those who
received the usual guideline [31]. Another RCT found
that wording a guideline in behaviourally specific terms
enhanced patient attitude about, confidence in ability to
use, and intention to use the recommendations [32,33].
Furthermore, the information relevant to various guide-
line users may differ. Users include clinicians who deliver
care, and managers and policy makers who must recon-
cile the competing interests of multiple stakeholders to
make decisions about mobilizing organizational or sys-
tem level resources [34]. Research suggests that indivi-
dual clinicians value an easy-to-use format, evidence
clarity and validity, details about competency and train-
ing requirements, and guidance on how to blend experi-
ence with evidence when applying the recommendations
to individual patients, and engage patients in shared deci-
sion making [35-39]. Managers and policy makers want
guidelines to summarize resource or policy implications,
and be publicly available in different versions for various
purposes [40,41].
It appears that guideline format and content may be
important aspects of implementability that may influ-
ence use, and specific content may be required to
support different types of decision making, including
evidence-informed, experiential, shared, and resource
allocation decision making. Including implementability
information within guidelines to help users apply the
recommendations represents a less-threatening, prac-
tice-relevant approach to guideline implementation
compared with complex, costly, inconsistently effective
implementation strategies often viewed negatively by
guideline users [42]. It may be easier to modify the con-
tent and format of guidelines rather than the clinical
complexity of the recommendations. Finally, this
approach may be more feasible for guideline developers
to integrate with the processes they already use to create
guidelines regardless of health system or funding struc-
ture. Therefore, further investigation of how to make
guidelines more implementable is warranted.
To date, there has not been a systematic analysis of
guideline features that may improve their use. The pur-
pose of this study was to create a taxonomy of these
attributes, and assess whether current guidelines contain
these features, thereby identifying ways in which guide-
lines could be modified to potentially improve their use.
This implementability framework could inform the
development of modified guidelines or adjunct products,
and evaluation of how various attributes influence per-
ceptions about, and use of guidelines, prior to more
definitive testing of whether their inclusion indeed
improves use.
Methods
This study involved two key phases. The first phase was
to develop an implementability framework of guideline
format and content apart from clinical recommenda-
tions that are desired by users, or influence use of
guidelines. The second phase was to use the framework
assembled in phase one to examine the content of cur-
rent practice guidelines, and refine or extend the
framework.
Development of an implementability framework
Approach
Given the lack of controlled and observational studies
on this topic, the methods were based on a modified
meta-narrative approach [43]. The meta-narrative
approach is more suitable than a systematic review for
conceptually examining literature that may be limited in
quantity and quality, and vary in disciplinary focus and
study design. It involves periodic input from a multidis-
ciplinary research team to define the objectives and
interpret the findings from a variety of conceptual per-
spectives. In this case, we used a modified approach that
focused on healthcare literature rather than other disci-
plines, but were inclusive of a variety of study designs.
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One individual with health librarian training and experi-
ence conducting different types of reviews (ARG) per-
formed searches in MEDLINE and EMBASE from 1996
to August 2009. We purposely used a broad search
strategy based on few terms (practice guidelines as topic
AND guideline adherence AND attitude of health per-
sonnel or decision making, organizational or policy
making) knowing that sensitivity and specificity would
be limited. Two individuals independently selected eligi-
ble items. Eligible titles included empirical quantitative
(meta-analyses, surveys, observational studies, rando-
mized trials) or qualitative (reviews/conceptual analyses,
interviews, focus groups) studies published in English
language peer-reviewed journals describing guideline
features desired by, or influencing the knowledge, deci-
sion making, or behaviour of health professionals. Stu-
dies were ineligible if they focused on guideline-
informed tools such as clinical pathways; guidelines for
non-medical interventions; clinical effectiveness of medi-
cal interventions; involved students, trainees, or patients
as participants; investigated guideline use without exam-
ining views about guideline features that influenced use;
evaluated interventions to promote guideline use;
concluded that guideline features could be improved to
promote their use without evaluating those features; or
were in the form of abstracts, letters, commentaries, or
editorials. All items selected by at least one individual
were retrieved, and one individual extracted data. Qual-
ity assessment of studies was not undertaken to be
inclusive of all relevant implementability elements.
Data analysis
Desirable or influential features potentially associated
with guideline use were annotated in eligible studies,
then tabulated. This tabulated list included the features
of guidelines identified in each study as desirable or
influencing guideline use. From this list, common items
were categorized and defined. Findings were reviewed
independently, and as a group by the study team, which
included individuals with clinical, management, and
research perspectives; grounding in the disciplines of
knowledge translation/implementation science, psychol-
ogy, and organizational behaviour; and experience in
guideline development, guideline implementation, and
performance improvement. The research team met in
person and by teleconference to review and refine the
draft framework. This largely involved minor edits to
domain definitions. The draft framework was used to
guide content analysis of guidelines, which expanded the
number of elements in framework domains. This
extended framework was reviewed and refined by the
research team in person and by teleconference.
Application of the implementability framework
Approach
Manifest content analysis was used to examine guide-
lines for the presence of implementability elements.
This is a method that describes explicit content as
reported in written, verbal, or visual communication
qualitatively and/or quantitatively, without interpretation
of its underlying meaning [44]. We selected a directed
approach, which seeks to validate and extend elements
in a framework [45]. This means data are coded using
elements in the draft framework, and data that cannot
be coded are analyzed to assess if they represent a new
element.
Sampling
Individual guidelines were chosen as the unit of analysis.
Guidelines on topics representing a high burden of ill-
ness in primary (diabetes, hypertension) and institutional
care (chronic ulcer, heart failure) were selected from
among those evaluated by the Guidelines Advisory
Committee (GAC, http://www.gacguidelines.ca), a pro-
gram that systematically appraised and summarized
guidelines. Eligible guidelines included all those identi-
fied by GAC using a comprehensive search strategy and
judged by trained experts using the Appraisal of Guide-
lines Research and Evaluation (AGREE) instrument to
be high quality that covered comprehensive manage-
ment of these conditions and were publicly available
[46].
Data collection
Full versions of selected guidelines and adjunct products
were retrieved from sponsor web sites. A form was
developed to extract content from each guideline
according to the implementability framework. Round
one extraction was performed by ARG. This produced
an expanded, revised framework, used by ARG to again
extract data from each guideline. A research assistant
independently reviewed the features in all guidelines,
and a physician (VAP) independently reviewed coding of
the elements for two guidelines on each clinical topic.
ARG met with both independent reviewers to compare
findings and resolve differences through discussion.
Data analysis and interpretation
Extracted data was tabulated. The presence of imple-
mentability elements within sampled guidelines was
described using summary statistics including number,
proportion, and mean or median. Detailed content was
analyzed using Mays’ narrative review method, based on
verbatim reporting, rather than statistical summary or
conceptual analysis of information [47]. Data were
examined to discuss the number of guidelines addres-
sing each element overall and by topic, thereby identify-
ing opportunities for modifying guideline format or
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reviewed by the research team in person and by
teleconference.
Results
A total of 18 studies were reviewed from among 1,348
(441 MEDLINE, 907 EMBASE) identified by the litera-
ture search (Table 1). The vast majority of literature
search results were ineligible because they evaluated the
clinical effectiveness of medical interventions or inter-
ventions to promote guideline use. Eligible studies
included one RCT, one observational study, four sys-
tematic reviews, three surveys, two modified Delphi stu-
dies, and six qualitative studies involving either focus
groups or interviews. Based on features desired by, or
influencing guideline use among primarily physicians, a
preliminary taxonomy of eight implementability domains
emerged, including adaptability, usability, validity,
applicability, communicability, accommodation, imple-
mentation, and evaluation (Table 2).
Based on the implementability framework, data were
extracted from 20 guidelines on the management of dia-
betes (n = 8), hypertension (n = 4), leg ulcer (n = 3) and
h e a r tf a i l u r e( n=5 )f r o me i g h td i f f e r e n tc o u n t r i e s ,
including Australia (n = 2), Brussels (n = 1), Canada
(n = 4), the Netherlands (n = 1), New Zealand (n = 1),
Singapore (n = 1), the United Kingdom (n = 4), and
United States (n = 6) (Table 3). Most were produced by
professional associations or government agencies (75%).
The final framework derived through content analysis of
guidelines included 22 elements organized within eight
domains (Table 4).
Table 1 Studies describing guideline features that may influence use
Study Design Guideline features encouraging use
Brouwers
2009
Canada [48]
Survey of 756 physicians of various specialties between 1999
and 2005 on intended use of 84 cancer guidelines yielding
4,091 surveys
Strong supporting evidence, flexibility of recommendations
to local context
Wakkee
2008
Netherlands [49]
Questionnaire of 261 dermatologists on characteristics of
specific guideline
Concise recommendations
Nuckols
2008
United States [39]
Modified Delphi panel of 11 physicians of various specialties Strong supporting evidence, flexibility of recommendations
to patient needs and preferences
Francke
2008
Netherlands [7]
Meta-review of 12 systematic reviews on guideline
implementation:
1. 41 cross sectional pre-/post-test studies or controlled trials Easily accessible, strong supporting evidence, explicit
resource implications, flexibility of recommendations to local
2. 76 survey and qualitative studies
3. 91 randomized, cross-over, balanced incomplete block
design, controlled before/after, interrupted times series
studies
context, concise recommendations
4. 61 mixed methods studies with focus on randomized or
controlled trials
5. 23 studies of various quantitative designs
6. 235 randomized or controlled trials, controlled before/after
or interrupted time series designs
7. 40 randomized or controlled trials or before/after studies
8. 15 randomized or controlled trials, pre-/post-test studies
and one systematic review
9. 59 studies of various quantitative or qualitative or mixed
design
10. 6 randomized controlled trials, time series or before/after
studies and 8 studies of mixed design
11. 18 ranodmized or controlled trials, before/after or
interrupted time series studies
12. 20 randomized or controlled trials, case series or case
reports
Cochrane
2007
United States [30]
Systematic review of 256 studies of guideline implementation
(178 surveys, 16 focus group studies, 18 interview studies, 44
mixed methods studies)
Easily accessible, strong supporting evidence, flexibility of
recommendations to local context, concise
recommendations
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Carlsen
2007
Norway [50]
Qualitative analysis of six focus groups involving 27 general
practitioners
Trustworthy, suit patients, recommended action is feasible
Carlsen
2007
Norway [42]
Systematic review of 12 qualitative studies (7 focus group
studies, 5 interview studies) evaluating general practitioner
attitudes about guidelines
Authorship familiarity, flexibility of recommendations to
patient needs and preferences, short and concise, include
patient leaflets
Jones
2007
Canada [51]
Qualitative analysis 28 interviews with physicians and nurses
in four intensive care units
Easily accessible, accompanying tools such as checklists,
strong supporting evidence, concise recommendations
Thomason
2007
United States [52]
Survey and focus groups with 60 physicians and nurses who
attended a national conferences
Strong supporting evidence, concise recommendations
Sinuff
2007
Canada [53]
Qualitative analysis of interviews with 30 physicians and
nurses at one hospital
Easily accessible, accompanying tools such as algorithms or
pocket cards, concise recommendations
McKinlay
2004
New Zealand [54]
Qualitative analysis of interviews with 13 general practitioners
from five sites
Authorship familiarity, variety of print and electronic formats
Shiffman
2003
United States [55]
Modified Delphi process involving representatives from 22
organizations active in guideline development
Explicit resource implications, suggestions for auxiliary
documents for providers or patients, evaluative data
collection tools
Price
2001
United States [56]
Discourse analysis of laboratory study using clinical scenarios
and guidelines of different formats involving three general
practitioners and three endocrinologists
Algorithmic guidelines were useful for clinical problem
solving, textual guidelines were useful for learning
Vinker
2000
Israel [57]
Questionnaire of 293 general practitioners and family
physicians participating in educational programs over two
months
Strong supporting evidence, flexibility of recommendations
to patient needs and preferences, concise recommendations
Harris
2000
United States [42]
Questionnaire and focus groups with an undisclosed sample
drawn from 304 general practitioners based at 16 sites
Accompanying tools such as checklists and standard orders,
summaries such as algorithms or diagrams, navigational
support such as color-coded tabs, evaluative data collection
tools, accessible by computer, information guides for
patients
Shekelle
2000
United States [31]
Randomized controlled trial of questionnaire on intent to use
guidelines among 545 general internists, neurologists and
physical medicine specialists who received usual guideline or
guideline modified with clinical vignettes
Clinical vignettes describing application of guidelines
according to patient needs and preferences
Cabana
1999
United States [58]
Systematic review of 76 journal articles on barriers to
guideline adherence among physicians
Strong supporting evidence, authorship familiarity, easily
accessible, concise recommendations, flexibility of
recommendations to patient needs and preferences
Grol
1998
Netherlands [37]
Observational study involving 12,880 decisions made by 61
general practitioners based on 12 guidelines with various
attributes rated by participants
Strong supporting evidence, concise recommendations,
explicit resource implications
Table 2 Initial framework of guideline implementability
Domain Definition
Adaptability The guideline is available in a variety of versions for different users or purposes.
Usability Content is presented, organized, or formatted to enhance the ease with which the guideline can be employed.
Validity Evidence is summarized and presented such that its quantity and quality are apparent, and it can be easily reviewed, understood,
and interpreted.
Applicability Contextual or supplementary clinical information is provided by which to interpret and apply the recommendations for individual
patients.
Communicability Information is included to support discussions with patients, or patient involvement in decision making.
Accommodation Costs, resources, competencies and training, technical specifications, and anticipated impact required to accommodate use are
identified.
Implementation Strategies for identifying barriers of use, and selecting, planning, and applying promotional strategies are described.
Evaluation Performance measures for audit or monitoring are included.
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summarized in Table 5. One-half of the guidelines were
published in journals or available in a summary version,
and one-quarter were available as downloadable digital
or patient versions. Many were very large documents
with median pages of 72.5 (range 21.0 to 878.0), median
number of references of 230.5 (range 15.0 to 3,487.0),
and median number of recommendations of 41.5 (range
8.0 to 214.0). Most featured a table of contents (75.0%),
and just over one-half included a recommendation sum-
mary (55.0%) or algorithm (65.0%). Nearly all guidelines
used an evidence grading system (95.0%). Few summar-
ized the evidence in tabular format (25.0%).
Content elements that may facilitate guideline use are
summarized in Table 6. Clinical considerations by which
to individualize recommendations were available in most
Table 3 Guidelines reviewed by type of organization and clinical topic
Type of organization Overall Diabetes Hypertension Leg Ulcer Heart Failure
Academic 1 1 ———
Government 6 2 2 1 1
Expert panel or consortium 2 1 — 1 —
Professional association 9 3 2 1 3
Private, nonprofit 2 1 ——1
Total 20 8 4 3 5
Table 4 Final framework of guideline implementability
Domain Element Examples
Usability Navigation Table of contents
Evidence format Narrative, tabulated or both
Recommendation
format
Narrative, graphic (algorithms) or both; Recommendation summary (single list in full or summary version)
Adaptability Alternate versions Summary (print, electronic for PDA); Patient (tailored for patients/caregivers); Published (journal)
Validity Number of references Total number of distinct references to evidence upon which recommendations are based
Evidence graded A system is used to categorize quality of evidence supporting each recommendation
Number of
recommendations
Total number of distinct recommendations (sub-recommendations considered same)
Applicability Individualization Clinical information (indications, criteria, risk factors, drug dosing) that facilitates application of the
recommendations explicitly highlighted as tips or practical issues using sub-titles or text boxes, or
summarized in tables and referred to in recommendations or narrative contextualizing recommendations
Communicability Patient education or
involvement
Informational or educational resources for patients/caregivers, questions for clinicians to facilitate
discussion, or contact information (phone, fax, email or URL) to acquire informational or educational
resources
Accommodation Objective Explicitly stated purpose of guideline (clinical decision making, education, policy, quality improvement)
Users Who would deliver/enable delivery of recommendations (individuals, teams, departments, institutions,
managers, policy makers, internal/external agents), who would receive the services (patients/caregivers)
User needs/values Identification of stakeholder needs, perspectives, interests or values
Technical Equipment or technology needed, or the way services should be organized to deliver recommendations
Regulatory Industrial standards for equipment or technology, or policy regarding their use
Human resources Type and number of health professionals needed to deliver recommended services
Professional Education, training or competencies needed by clinicians/staff to deliver recommendations
Impact Anticipated changes in workflow or processes during/after adoption of recommendations
Costs Direct or productivity costs incurred as a result of acquiring resources or training needed to
accommodate recommendations, or as a result of service reductions during transition from old to new
processes
Implementation Barriers/facilitators Individual, organizational, or system barriers that are associated with adoption
Tools Instructions, tools or templates to tailor guideline/recommendations for local context; Point-of-care
templates/forms (clinical assessment, standard orders)
Strategies Possible mechanisms by which to implement guideline/recommendations
Evaluation Monitoring Suggestions for evaluating compliance with organization, delivery and outcomes of recommendations,
including program evaluation, audit tools, and performance measures/quality indicators
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sisted of tables that summarized diagnostic or risk cri-
teria, pharmacologic dosing, indications for treatment or
referral, and management options (75.0%). All four
hypertension guidelines included specific skill-based
instructions for measuring blood pressure. Some guide-
lines featured sections explicitly labelled considerations
for either special populations( t w od i a b e t e sg u i d e l i n e s )
or by health system capacity (one diabetes guideline).
Two heart failure guidelines graphically highlighted con-
siderations within text boxes or balloons labelled prac-
tice points or tips. Less than one-half of the guidelines
included information to educate or engage patients
(50.0%). Of these, five provided information to help clin-
icians discuss relevant issues with patients, two included
information sheets for patients, and seven provided con-
tact information (phone number or web site) where
information for patients could be obtained.
No guidelines identified stakeholder needs or values,
or costs or impact associated with use. Few included
technical (45.0%), regulatory (15.0%), human resources
(5.0%), or professional competency (20.0%) information
required to accommodate guideline use. When included,
this content was generally limited in detail. For example,
technical guidance included: ‘organization of care to
deliver the above recommendations is largely concerned
with putting registration, recall and record systems in
place to ensure care delivery occurs for all people with
diabetes, and having the healthcare professionals trained
and available (D12)’ or ‘multidisciplinary care programs
improve patients’ quality of life, satisfaction with care,
and the risk of unplanned hospitalization for heart fail-
ure (HF23).’ Regulatory instructions included: ‘blood
pressure instruments must be properly validated and
regularly recalibrated according to manufacturer instruc-
tions (H04).’ Guidance for human resources included:
‘interdisciplinary team comprised of family physician,
diabetes educators (nurse, dietician), and community
health support (D15).’ Professional competency criteria
included: ‘compression bandages should be applied by a
practitioner who has received training in their applica-
tion (LU05).’
One-half of the guidelines included performance mea-
sures that could be used to monitor recommended
Table 5 Format elements of reviewed guidelines
Domain/Element Statistic Overall
(n = 20)
Diabetes (n = 8) Hypertension (n = 4) Leg Ulcer (n = 3) Heart Failure (n = 5)
Adaptability
Journal version n (%) 10 (50.0) 4 (50.0) 3 (75.0) 0 (0.0) 3 (60.0)
PDA version n (%) 5 (25.0) 3 (37.5) 1 (25.0) 0 (0.0) 1 (20.0)
Short version n (%) 9 (45.0) 0 (0.0) 3 (75.0) 2 (66.7) 4 (80.0)
Patient version n (%) 4 (20.0) 0 (0.0) 2 (50.0) 0 (0.0) 2 (40.0)
Usability
Table of contents n (%) 15 (75.0) 6 (75.0) 2 (50.0) 3 (100.0) 4 (80.0)
Number of pages mean 120.2 199.5 45.8 60.7 88.4
med 72.5 95.5 46.0 46.0 80.0
min 21.0 21.0 39.0 21.0 25.0
max 878.0 878.0 52.0 115.0 163.0
Number of recommendations mean 71.7 120.8 10.5 41.3 60.4
med 41.5 126.5 9.5 39.0 43.0
min 8.0 24.0 8.0 20.0 9.0
max 214.0 214.0 15.0 65.0 118.0
Recommendation summary n (%) 11 (55.0) 3 (37.5) 4 (100.0) 2 (66.7) 2 (40.0)
Recommendation algorithm n (%) 13 (65.0) 2 (25.0) 4 (100.0) 2 (66.7) 5 (100.0)
Validity
Number of references mean 452.0 849.9 128.8 111.7 278.2
med 230.5 247.0 80.0 83.0 252.0
min 15.0 15.0 24.0 72.0 218.0
max 3,487.0 3,487.0 331.0 180.0 347.0
Evidence graded n (%) 19 (95.0) 7 (85.5) 4 (100.0) 3 (100.0) 5 (100.0)
Evidence format narrative 15 (75.0) 6 (75.0) 4 (100.0) 2 (66.7) 3 (60.0)
narrative + tabular 5 (25.0) 2 (25.0) — 1 (33.3) 2 (40.0)
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actively promote guideline use, none thoroughly
described how to undertake or evaluate this process. For
example: ‘implementation may be supported by a variety
of activities including continuing education and training,
and clinical audit (LU07)’ or ‘implementation programs
are needed because it has been shown that the outcome
of a disease may be favourably influenced by thorough
application of clinical recommendations (HF26).’ Less
than a third included templates such as order forms or
assessment checklists (30.0%), and fewer than this
offered cursory instructions for identifying barriers of
use (15.0%) or tailoring the guidelines to suit local cir-
cumstances (2.0%).
Discussion
Relatively few studies published over the last 15 years
specifically examined guideline features desired by, or
associated with use among health professionals, most of
these focused on physicians, and it does not appear that
studies were informed by preceding research to build a
cumulative body of knowledge. Considerable research
has examined other factors influencing guideline use
such as physician and organizational characteristics, but
these studies were not eligible for this review, nor were
numerous studies that examined general attitudes to
guidelines on specific clinical topics. Review of 18 eligi-
ble studies revealed several features related to format or
content that may positively influence guideline use, and
this was expanded by reviewing the content of high
quality international guidelines on various clinical topics.
Most guidelines we examined contained a large volume
of graded evidence and numerous tables featuring com-
plementary clinical information to the point of being
cumbersome, despite the presence of navigational fea-
tures such as tables of contents. Few contained addi-
tional features specified by users or suggested by
research to improve guideline use. Guideline use could
Table 6 Content elements of reviewed guidelines
Domain/Element Overall
(n = 20)
Diabetes
(n = 8)
Hypertension (n = 4) Leg Ulcer
(n = 3)
Heart Failure
(n = 5)
n%n% n % n % n %
Applicability
Individualization 18 90.0 6 75.0 4 100.0 3 100.0 5 100.0
Communicability
Patient informed care 10 50.0 4 50.0 2 50.0 1 33.3 3 60.0
Accommodation
Objectives:
Clinical 20 100. 8 100. 4 100.0 3 100.0 5 100.0
Education 1 0 1 0 —— — — — —
Policy — 5.0 — 12.5 —— — — — —
Quality improvement 2 —
10.0
1 —
12.5
—— — — — —
Users 12 60.0 5 62.5 1 25.0 2 66.7 4 80.0
User needs/values 0 0.0 0 0.0 0 0.0 0 0.00 0 0.0
Technical 9 45.0 3 37.5 1 25.0 1 33.3 4 80.0
Regulatory 3 15.0 0 0.0 3 75.0 0 0.0 0 0.0
Human resources 1 5.0 1 12.5 0 0.0 0 0.0 0 0.0
Professional 4 20.0 0 0.0 1 25.0 2 66.7 1 20.0
Impact 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Costs 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Implementation
Barriers 3 15.0 1 12.5 2 20.0 0 0.0 0 0.0
Tailoring instructions 2 10.0 0 0.0 0 0.0 2 66.7 0 0.0
Point-of-care tools/forms 6 30.0 3 37.5 0 0.0 2 66.7 1 20.0
Implementation strategies 9 45.0 4 50.0 1 25.0 2 66.7 2 40.0
Evaluation
Evaluation instructions 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Performance measures 10 50.0 4 50.0 2 50.0 2 66.7 2 40.0
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for different purposes, incorporating summaries of evi-
dence and recommendations, including information to
facilitate interaction with and involvement of patients,
outlining resource implications, and describing how to
locally plan, promote, and monitor guideline use. There
were no consistent trends by guideline topic.
Our findings simply suggest that more guidelines
could be modified to include implementability content,
but it remains unclear how various implementability fea-
tures might influence guideline use. A recent analysis
recommended that the reliability, relevance, and read-
ability of knowledge resources be improved to support
evidence-based decision making [48]. Evidence is just
one of several factors that inform decisions about guide-
line use [49]. In reality, clinicians must often draw upon
expertise and experience to consider what is best for
and desired by those receiving care, but have expressed
uncertainty about how to balance evidence with profes-
sional judgment and patient preferences, and the need
for guidance to support these decisions [50,51]. Further-
more, clinical decisions about guideline use are influ-
enced by the availability and mobilization of
organizational or system level resources, which are gov-
erned by managers and policy makers who must recon-
cile the competing interests of multiple stakeholders
[34]. Further insight could be gained by drawing upon
decision science to examine the cognitive processes
underlying guideline use. Considerable research has
established that humans are not rational decision
makers who identify alternative options, compare them
on the same set of evaluative dimensions, and generate
probability and utility estimates for different courses of
action [52]. Instead, it appears that a combination of
intuitive (based on experience) and analytic (based on
mental simulation) mechanisms are employed [53]. This
is particularly true in ‘naturalistic’ situations where deci-
sions are complex; the quantity of information may be
large or its implications ambiguous; goals may be shift-
ing, poorly defined, or competing; and decisions have
high stakes and are made within a dynamic environment
under time constraints, as is true of the healthcare sec-
tor [54]. It has been suggested that guidelines include
content that mediates decisions among different stake-
holders in a manner consistent with these cognitive pro-
cesses [55]. Thus, elements in the proposed framework
may have impact on two dimensions: support for differ-
ent types of decision making (evidence-informed, experi-
ential, shared, allocation/policy) by providing particular
information and/or tools, and support for different types
of decision-making processes (intuitive, analytic) by
making explicit the options for, and implications of
alternate choices. This may influence attitudes about
guideline relevance and confidence in choosing a course
of action, which may be associated with use [56]. While
the concept of implementability is not new, the pro-
posed framework is unique because it includes features
that may be relevant not only to individuals, but to the
managers and policy makers that govern the environ-
ment within which individuals function, and because it
offers a novel way to improve guideline use by consider-
ing how to support different types and processes of
decision making [28,57,58].
Interpretation of the findings may be limited in several
ways. We studied guidelines relevant to primary and
institutional care. Other guidelines relevant to specialty
care may differ in their implementability characteristics.
However, while we reviewed few guidelines, they were
specifically selected to represent different topics, coun-
tries, and types of developer. Each element may not
have been relevant to all guidelines reviewed, but this
exercise serves as an exploratory, baseline effort to
develop the framework according to content available in
a range of guidelines. The literature on this topic is
sparse, and referred to conceptually in a variety of ways
and therefore not consistently indexed in literature data-
bases; the search strategy used was purposely broad in
an attempt to identify all relevant studies, but it may
not have retrieved all studies describing guideline fea-
tures desired by, or influencing the behavior of health
professionals. We are currently in the process of con-
ducting a systematic conceptual review of theoretical
and empirical research on the mechanisms by which
implementability elements influencing decision making
about guideline use. Still, by assembling a rudimentary
implementability framework that was expanded by
review of guideline content, numerous opportunities
were revealed for potentially improving guideline devel-
opment and use.
Prior to testing these hypotheses, practical issues must
be considered. Robust methods by which to operationa-
lize concepts more specifically to enable accurate data
capture would require further development. New gov-
ernance structures may be required to accommodate the
development of guidelines with these features. Future
research should validate the framework by applying it to
different types of guidelines, and by soliciting feedback
from guideline development and implementation
experts, clinicians, managers, policy makers, and
patients/caregivers to further clarify and expand on its
elements. Research is also required to examine precisely
how the elements of implementability influence guide-
line use. Based on an expanded stakeholder-defined
implementability framework, the cost-effectiveness of
tailored guidelines or adjunct products could be estab-
lished by examining short-term outcomes predictive of
guideline use such as recall, attitude to, confidence in,
and adoption intention, then long-term objective
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Page 9 of 11outcomes reflecting the adoption of processes and asso-
ciated patient care outcomes.
Conclusions
Numerous opportunities were identified by which guide-
lines could be modified to potentially facilitate their use.
New governance structures may be required to accom-
modate development of guidelines with these features.
Further research is needed to validate the proposed fra-
mework of guideline implementability, develop methods
for preparing this information, and evaluate how inclu-
sion of this information influences guideline use.
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